LGALS3 and metabolic dysfunction-associated steatohepatitis: In a diet-induced mouse MASH model, belapectin was shown to reduce Gal-3 expression in liver macrophages, reduce hepatocyte fat accumulation and ballooning, and reduce fibrosis as measured by liver collagen levels [34].